Merck
MRK
$84.07
Share price
0.44%
Change (1 day)
-34.38%
Change (1 year)
Categories
Merck (MRK) - Total assets
Total assets on the balance sheet as of March 2025 : $115.12 Billion USD
According to Merck's latest financial reports the company's total assets are $115.12 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Merck - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $117.10 B | 9.78% |
| 2023-12-31 | $106.67 B | -2.28% |
| 2022-12-31 | $109.16 B | 3.28% |
| 2021-12-31 | $105.69 B | 15.4% |
| 2020-12-31 | $91.58 B | 8.52% |
| 2019-12-31 | $84.39 B | 2.13% |
| 2018-12-31 | $82.63 B | -5.96% |
| 2017-12-31 | $87.87 B | -7.87% |
| 2016-12-31 | $95.37 B | -6.2% |
| 2015-12-31 | $101.67 B | 3.58% |
| 2014-12-31 | $98.16 B | -7.08% |
| 2013-12-31 | $105.64 B | -0.46% |
| 2012-12-31 | $106.13 B | 0.96% |
| 2011-12-31 | $105.12 B | -0.62% |
| 2010-12-31 | $105.78 B | -5.82% |
| 2009-12-31 | $112.31 B | 137.98% |
| 2008-12-31 | $47.19 B | -2.39% |
| 2007-12-31 | $48.35 B | 8.48% |
| 2006-12-31 | $44.56 B | -0.62% |
| 2005-12-31 | $44.84 B | 5.34% |
| 2004-12-31 | $42.57 B | 4.89% |
| 2003-12-31 | $40.58 B | -14.66% |
| 2002-12-31 | $47.56 B | 8.04% |
| 2001-12-31 | $44.02 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $208.02 B | 80.70% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $193.67 B | 68.23% | 🇺🇸 USA |
 Eli Lilly LLY | $89.38 B | -22.35% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $92.42 B | -19.71% | 🇺🇸 USA |
 Sanofi SNY | $142.69 B | 23.95% | 🇫🇷 France |
 GlaxoSmithKline GSK | $78.43 B | -31.87% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $38.41 B | -66.63% | 🇮🇱 Israel |
 Novartis NVS | $99.94 B | -13.19% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $81.44 B | -29.25% | 🇺🇸 USA |
 Amgen AMGN | $89.36 B | -22.37% | 🇺🇸 USA |